<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://10.9.150.37:8080/dspace//handle/atmiyauni/1432">
<title>03. M.Pharm Students Dissertation</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/1432</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://10.9.150.37:8080/dspace//handle/atmiyauni/2286"/>
<rdf:li rdf:resource="http://10.9.150.37:8080/dspace//handle/atmiyauni/1434"/>
</rdf:Seq>
</items>
<dc:date>2026-05-10T15:10:36Z</dc:date>
</channel>
<item rdf:about="http://10.9.150.37:8080/dspace//handle/atmiyauni/2286">
<title>Formulation and Evaluation of Clindamycin Phosphate Microsponge Gel for Topical Drug Delivery</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/2286</link>
<description>Formulation and Evaluation of Clindamycin Phosphate Microsponge Gel for Topical Drug Delivery
Kadivar, Richa; Joshi, Rachana
Clindamycin is a potent lincosamide antibiotic against susceptible anaerobic&#13;
bacteria and gram-positive aerobes. Furthermore, CLN also has anti-inflammatory&#13;
activities. It is applied topically in the management of acne vulgaris.The current&#13;
research was focused on gel loaded for the topical delivery to Clindamycin&#13;
phosphate to overcome short half life problem of the drug and to minimize the side&#13;
effects of drug with conventional gel. The FTIR study revealed that there was no&#13;
interaction between drug and polymer and the combination is suitable for&#13;
preparation of microsponges. Clindamycin phosphate loaded microsponges were&#13;
prepared by oil in oil emulsion solvent diffusion method as the drug is highly water&#13;
soluble and belongs to BCS class III. The microsponges were prepared by using&#13;
ethyl cellulose as the polymer and incorporated into carbopol gel. The&#13;
microsponges were evaluated for visual inspection, % yield, % drug content, %&#13;
entrapement efficiency and particle size. The effect of formulation variables like&#13;
stirring speed and drug:polymer ratio were evaluated on microsponges. The&#13;
optimized formulation with drug:polymer ratio of 1:1, stirring speed of 1000rpm&#13;
had the drug content of 78.69% and percent entrapement efficiency was found to&#13;
be 87.94% The results concluded that as the drug:polymer ratio increases, drug&#13;
content and entrapement efficiency decreases. The particle size of optimized batch&#13;
of microsponges was found to be 37.44μm. The results of particle size analysis&#13;
concluded that as the drug:polymer ratio increases, particle size increases. The&#13;
microsponges of batch CLPA1-CLPA9 were subjected to in-vito drug release&#13;
study by Franz diffusion cell apparatus. The batch showed the controlled release of&#13;
95.49% of drug release at 10 hrs. The results of in-vitro drug release showed that&#13;
as the drug:polymer ratio increases, more controlled release formulation is&#13;
obtained. The microsponges were incorporated into carbopol gel was evaluated for visual inspection, pH, spreadability and stability of gel at room temperature for 1&#13;
month. The transparent white microsponge gel had the pH of 6.38 with&#13;
spreadability of 7.05 g cm/s. The gel was found to be stable after 1 month. In-vitro&#13;
antibacterial activity was observed for microsponge gel and compared with&#13;
marketed 1%w/w CLP gel (Clindac A).
</description>
<dc:date>2024-11-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://10.9.150.37:8080/dspace//handle/atmiyauni/1434">
<title>Solubility Enhancement Of Poorly Soluble Drugs By Formulation Of Solid Dispersion Using Soluplus® As A Carrier</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/1434</link>
<description>Solubility Enhancement Of Poorly Soluble Drugs By Formulation Of Solid Dispersion Using Soluplus® As A Carrier
Sheikh, Mohammed Farhan M.; Ughreja, Reena
Treatment of tuberculosis makes great use of rifampicin. While Abiraterone Acetate is generally&#13;
used for the treatment of prostate cancer, Duloxetine Hydrochloride is advised for the treatment of&#13;
major depressive disorder. Still, the low water solubility of all these drugs affects their&#13;
bioavailability. Thus, this work sought to generate solid dispersions thereby enhancing the&#13;
solubility and hence the dissolution rate of Rifampicin, Duloxetine hydrochloride, and Abiraterone&#13;
Acetate. Soluplus® was used as a carrier to enhance solubility; phase solubility investigations&#13;
carried out in preliminary trials helped to ascertain the ratio. First investigations were carried out&#13;
to select the suitable solvent and techniques; thereafter, solid dispersions were developed. The&#13;
Physical characterization was done by DSC and FT-IR. DSC was performed to determine the&#13;
thermal characteristics of the drug and FT-IR was performed to determine the compatibility&#13;
between the drug and polymer. Melt and solvent evaporation techniques were used to produce the&#13;
solid dispersion. The batches had ratios ranging from 1:1, 1:2, and 1:3. %Drug content, %yield,&#13;
solubility studies, and in-vitro dissolution studies were among the evaluation parameters&#13;
performed for the solid dispersion assessment. The batch showing good results was selected for&#13;
further investigation with XRD, DSC, and FT-IR methods. The best batches of all the drugs&#13;
(Rifampicin, Duloxetine HCL and Abiraterone Acetate) showed enhancement in the solubility and&#13;
dissolution rate.
</description>
<dc:date>2024-07-16T00:00:00Z</dc:date>
</item>
</rdf:RDF>
